Furthermore, association of p-p38 with telomeric TRF2 was confirmed by co-immunoprecipitation assay in HNSCC patient tumor lysates followed by immunoblotting with anti-TRF2, anti-p-p38 and anti p38 antibodies (Fig. 4d–f). This evidence concerns the gene MAPK14 and neoplasm.